Jenewon Levofloxacin Injection (Levofloxacin Hydrate)

Adult administration

Administer via slow intravenous infusion once or twice a day. The dose should be determined based on the type and severity of the infection and the susceptibility of the causative bacteria, with the option to switch to oral administration after intravenous treatment for a few days, depending on the patient’s condition. The administration duration should be at least 48-72 hours after achieving evidence of fever reduction or sterilization, with a maximum administration of up to 14 days. Administered through intravenous infusion once or twice a day with a minimum infusion time of 60 minutes. Normal renal

This drug may cause tendon issues such as tendinitis and tendon rupture, so discontinue use immediately if pain or inflammation in the tendons occurs. It may also affect peripheral neuropathy or the central nervous system, so if neurological symptoms appear, consult a physician promptly. Patients with myasthenia gravis may experience exacerbation of symptoms and should avoid this drug. When used as an injection, it should be infused slowly over a specified time, and if blood pressure drops sharply during infusion, administration should be stopped immediately. Concurrent use with corticosteroids increases the risk of tendon rupture, so co-administration should be avoided. Allergic reactions may manifest as skin rashes, hives, and difficulty breathing; if such symptoms occur, stop use immediately and inform medical staff. Gastrointestinal symptoms may include nausea, diarrhea, and abdominal pain, and if discomfort is severe, consult with medical personnel. It may affect the neurological and psychiatric systems, causing headaches, dizziness, insomnia, and in severe cases, hallucinations or seizures; report any abnormal symptoms immediately. Cardiovascular side effects may include tachycardia, hypotension, and rarely cardiac rhythm disorders, so caution is needed. Especially in the elderly or patients with compromised renal function, dosage adjustments may be necessary, and diabetic patients taking blood sugar control drugs should closely monitor blood sugar levels. Pregnant women or those who may become pregnant, nursing mothers, and growing children or adolescents should not use this drug. Dizziness or drowsiness may occur while driving or operating machinery, so caution is needed. This drug may interact with other medications, so if you are taking other medications, be sure to inform the medical staff. In cases of overdose, central nervous system symptoms and cardiac side effects may appear, so if suspected, visit a hospital immediately. This drug may react sensitively to sunlight; thus, avoid strong sunlight or UV exposure during treatment, and discontinue use if skin abnormalities occur. To use this drug safely, strictly follow the doctor's instructions and consult a specialist immediately if any unusual symptoms occur.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, high fever with severe rashes, blisters, skin peeling, pain in mucous membranes of mouth/eyes, severe skin reactions, asthma attacks, breathing difficulties alongside cough and fever, jaundice (yellowing of skin or eyes), profound lethargy, liver abnormalities (jaundice), sudden and severe headache, lightning.

Mild side effects

• Itching
• rash
• nausea
• diarrhea
• loss of appetite
• vomiting
• abdominal pain
• indigestion
• abdominal bloating
• constipation

Store this drug in a sealed container to protect it from air and light exposure, and keep it in a dark place away from direct sunlight. In addition, it should be stored at room temperature between 1 to 30 degrees Celsius to maintain its efficacy and safety.

Appearance

A yellow-transparent solution with a light green hue filled in a clear, transparent plastic container for infusion.

Package unit

For domestic use - 150 milliliters per package